Common use of Patents and Patent Applications Clause in Contracts

Patents and Patent Applications. All patents and patent applications owned by or licensed to the Company or its subsidiaries or under which the Company or its subsidiaries has rights have, to the knowledge of the Company, been duly and properly filed and maintained; to the knowledge of the Company, the parties prosecuting such applications have complied with their duty of candor and disclosure to the U.S. Patent and Trademark Office (the “USPTO”) in connection with such applications; and neither the Company nor any of its subsidiaries is aware of any facts required to be disclosed to the USPTO that were not disclosed to the USPTO and which would preclude the grant of a patent in connection with any such application or could form the basis of a finding of unenforceability with respect to any patents that have issued with respect to such applications.

Appears in 7 contracts

Samples: Sales Agreement (Seres Therapeutics, Inc.), Underwriting Agreement (Seres Therapeutics, Inc.), Placement Agency Agreement (Seres Therapeutics, Inc.)

AutoNDA by SimpleDocs

Patents and Patent Applications. All material patents and patent applications owned by or licensed to the Company or its subsidiaries have been duly and properly filed and each issued patent owned by, or under which the Company or its subsidiaries has rights have, to the knowledge of the Company, been duly and properly filed and exclusively licensed to the Company is being diligently maintained; to the knowledge of the Company, the parties prosecuting such applications have complied in all material respects with their duty of candor and disclosure to the U.S. Patent and Trademark Office (the “USPTO”) in connection with such applications; and neither the Company nor any of its subsidiaries is not aware of any facts required to be disclosed to the USPTO that were not disclosed to the USPTO and which would preclude the grant of a material patent in connection with any such application or could would reasonably be expected to form the basis of a finding of unenforceability invalidity with respect to any material patents that have been issued with respect to such applications.

Appears in 5 contracts

Samples: Underwriting Agreement (Addex Therapeutics Ltd.), Underwriting and Placement Agency Agreement (ObsEva SA), Sales Agreement (ObsEva SA)

Patents and Patent Applications. All patents and patent applications owned by or licensed to the Company or its subsidiaries or under which the Company or its subsidiaries has rights have, to the knowledge of the Company, been duly and properly filed and maintained, except where the failure to do so would not, singly or in the aggregate, reasonably be expected to result in a Material Adverse Effect; to the knowledge of the Company, the parties prosecuting such applications have complied with their duty of candor and disclosure to the U.S. Patent and Trademark Office (the “USPTO”) USPTO in connection with such applications; and neither the Company nor any of its subsidiaries is not aware of any facts required to be disclosed to the USPTO that were not disclosed to the USPTO and which would preclude the grant of a patent in connection with any such application or could would reasonably be expected to form the basis of a finding of unenforceability invalidity with respect to any patents that have issued with respect to such applications.

Appears in 4 contracts

Samples: Purchase Agreement (Paratek Pharmaceuticals, Inc.), Underwriting Agreement (Paratek Pharmaceuticals, Inc.), Underwriting Agreement (Paratek Pharmaceuticals, Inc.)

Patents and Patent Applications. All patents and patent applications owned by or licensed to the Company or its subsidiaries Group or under which the Company or its subsidiaries Group has rights have, to the knowledge of the Company, been duly and properly filed and maintained; to the knowledge of the Company, each individual associated with the parties prosecuting filing and prosecution of such patents and applications have has complied with their duty of candor and disclosure to the U.S. Patent and Trademark Office (the “USPTO”) in connection with such patents and applications; and neither the Company nor any of its subsidiaries is not aware of any facts information required to be disclosed to the USPTO that were was not disclosed to the USPTO and which would preclude the grant of a patent in connection with any such application or could form the basis prosecution of a finding of unenforceability with respect to any the aforementioned patents that have issued with respect to such and applications.

Appears in 1 contract

Samples: Placement Agency Agreement (ProQR Therapeutics N.V.)

AutoNDA by SimpleDocs

Patents and Patent Applications. All patents and patent applications owned by or licensed to the Company or its subsidiaries or under which the Company or its subsidiaries has rights have, to the knowledge of the Company, been duly and properly filed and maintained; to the knowledge of the Company, each individual associated with the parties prosecuting filing and prosecution of such patents and applications have has complied with their duty of candor and disclosure to the U.S. Patent and Trademark Office (the “USPTO”) in connection with such patents and applications; and neither the Company nor any of its subsidiaries is not aware of any facts information required to be disclosed to the USPTO that were was not disclosed to the USPTO and which would preclude the grant of a patent in connection with any such application or could form the basis prosecution of a finding of unenforceability with respect to any the aforementioned patents that have issued with respect to such and applications.

Appears in 1 contract

Samples: Underwriting Agreement (ProQR Therapeutics B.V.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!